Long-term treatment of type III hyperlipoproteinemia with clofibrate.

[1]  M. Karvonen,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. , 1979, British heart journal.

[2]  B. Suarez,et al.  Type III hyperlipoproteinemia: development of a VLDL ApoE gel isoelectric focusing technique and application in family studies. , 1979, The Journal of laboratory and clinical medicine.

[3]  G. Schonfeld,et al.  Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy. , 1979, The American journal of medicine.

[4]  G. Utermann,et al.  Polymorphism of apolipoprotein E , 1979, Clinical genetics.

[5]  D. Grafnetter,et al.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.

[6]  P. Demacker,et al.  A descriptive study of the different electrophoretic patterns on agarose of human serum very-low-density lipoproteins. , 1978, Clinical chemistry.

[7]  A. Gotto,et al.  Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia. , 1977, The American journal of medicine.

[8]  P. Demacker,et al.  Evaluation of the dual-precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum. , 1977, Clinical chemistry.

[9]  P. Demacker,et al.  An improved semi-automated method for the colorimetric determination of triglycerides in serum. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[10]  W. Hazzard,et al.  Broad-beta disease versus endogenous hypertriglyceridemia: levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia. , 1975, Metabolism: clinical and experimental.

[11]  P. Demacker,et al.  REDUCTION OF SERUM-ALKALINE- PHOSPHATASE BY CLOFIBRATE , 1975, The Lancet.

[12]  R. Levy,et al.  Type III hyperlipoproteinemia: an analysis of two contemporary definitions. , 1975, Annals of internal medicine.

[13]  R. Levy,et al.  The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. , 1975, Annals of internal medicine.

[14]  M. Marion.  The Familial Hyperlipoproteinemias , 1975 .

[15]  D. Porte,et al.  Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). , 1972, Metabolism: clinical and experimental.

[16]  D. Porte,et al.  Abnormal lipid composition of chylomicrons in broad-β disease (type III hyperlipoproteinemia) , 1970 .

[17]  E. Braunwald,et al.  Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. , 1970, The Journal of clinical investigation.

[18]  E. H. Strisower,et al.  Treatment of hyperlipidemias. , 1968, The American journal of medicine.

[19]  D. Blankenhorn,et al.  Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate. , 1968, Clinica chimica acta; international journal of clinical chemistry.

[20]  A. Raftery,et al.  A Stable Reagent for the Liebermann-Burchard Reaction. Application to Rapid Serum Cholesterol Determination , 1961 .

[21]  J. Kohn.  A Lipoprotein Staining Method for Zone Electrophoresis , 1961, Nature.

[22]  B ZAK,et al.  A new method for the direct determination of serum cholesterol. , 1953, The Journal of laboratory and clinical medicine.